Beacon Cancer Care ( Site 2052) — Post Falls, Idaho

Beacon Cancer Care ( Site 2052) is a clinical research site located in Post Falls, Idaho, United States 83854.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Beacon Cancer Care ( Site 2052) has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Head and Neck Neoplasms, Non-small Cell Lung Cancer, Lymphoma, Large B-Cell, Diffuse.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Post Falls

Browse all research sites in Idaho · View every site in Post Falls

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beacon Cancer Care ( Site 2052)?

Beacon Cancer Care ( Site 2052) has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beacon Cancer Care ( Site 2052) conducted?

Beacon Cancer Care ( Site 2052) has 5 clinical trials on record, with 4 currently active. Their work covers Head and Neck Neoplasms, Non-small Cell Lung Cancer, Lymphoma, Large B-Cell, Diffuse.

Is Beacon Cancer Care ( Site 2052) accredited by Crixeo Clinical Trials?

Beacon Cancer Care ( Site 2052) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beacon Cancer Care ( Site 2052)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.